NO20011615L - Fremgangsmåte for forhindring eller forsinkning av kateter- basert revaskularisering - Google Patents

Fremgangsmåte for forhindring eller forsinkning av kateter- basert revaskularisering

Info

Publication number
NO20011615L
NO20011615L NO20011615A NO20011615A NO20011615L NO 20011615 L NO20011615 L NO 20011615L NO 20011615 A NO20011615 A NO 20011615A NO 20011615 A NO20011615 A NO 20011615A NO 20011615 L NO20011615 L NO 20011615L
Authority
NO
Norway
Prior art keywords
procedure
preventing
based revascularization
delaying
catheter
Prior art date
Application number
NO20011615A
Other languages
English (en)
Norwegian (no)
Other versions
NO20011615D0 (no
Inventor
Donald Michael Black
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22289955&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20011615(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of NO20011615D0 publication Critical patent/NO20011615D0/no
Publication of NO20011615L publication Critical patent/NO20011615L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Surgical Instruments (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
NO20011615A 1998-09-30 2001-03-29 Fremgangsmåte for forhindring eller forsinkning av kateter- basert revaskularisering NO20011615L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10245798P 1998-09-30 1998-09-30
PCT/US1999/015385 WO2000018395A1 (en) 1998-09-30 1999-07-08 Method for preventing or delaying catheter-based revascularization

Publications (2)

Publication Number Publication Date
NO20011615D0 NO20011615D0 (no) 2001-03-29
NO20011615L true NO20011615L (no) 2001-04-24

Family

ID=22289955

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20011615A NO20011615L (no) 1998-09-30 2001-03-29 Fremgangsmåte for forhindring eller forsinkning av kateter- basert revaskularisering

Country Status (34)

Country Link
US (1) US20080119561A1 (et)
EP (1) EP1117392B1 (et)
JP (1) JP2002525321A (et)
KR (1) KR20010079955A (et)
CN (1) CN1197565C (et)
AP (1) AP1708A (et)
AT (1) ATE260100T1 (et)
AU (1) AU768474B2 (et)
BG (1) BG105471A (et)
BR (1) BR9914098A (et)
CA (1) CA2343299C (et)
CZ (1) CZ20011035A3 (et)
DE (1) DE69915084T2 (et)
DK (1) DK1117392T3 (et)
EA (1) EA007427B1 (et)
EE (1) EE200100199A (et)
ES (1) ES2214872T3 (et)
HR (1) HRP20010236A2 (et)
HU (1) HUP0103648A3 (et)
ID (1) ID30255A (et)
IL (2) IL141953A0 (et)
IS (1) IS5889A (et)
NO (1) NO20011615L (et)
NZ (1) NZ510500A (et)
OA (1) OA11787A (et)
PL (1) PL346980A1 (et)
PT (1) PT1117392E (et)
SI (1) SI1117392T1 (et)
SK (1) SK4122001A3 (et)
TR (1) TR200100901T2 (et)
UA (1) UA73292C2 (et)
WO (1) WO2000018395A1 (et)
YU (1) YU23901A (et)
ZA (1) ZA200102230B (et)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1216038T3 (da) 1999-08-30 2005-12-27 Sanofi Aventis Deutschland Anvendelse af inhibitorer af reninangiotensinsystemet ved forebyggelsen af cardiovaskulære hændelser
WO2001078747A1 (de) * 2000-04-18 2001-10-25 Bayer Aktiengesellschaft Verwendung von cse-hemmern zur behandlung von herzinsuffizienz
KR20030023698A (ko) * 2000-07-14 2003-03-19 워너-램버트 캄파니 카르복시알킬에테르를 사용하여 섭식 장애를 치료하는 방법
US6982251B2 (en) 2000-12-20 2006-01-03 Schering Corporation Substituted 2-azetidinones useful as hypocholesterolemic agents
HU230253B1 (hu) 2001-01-26 2015-11-30 Merck Sharp & Dohme Corp Peroxiszóma proliferátor-aktivált receptor (PPAR) aktivátor(ok) és szterin-abszorpció inhibitor(ok) kombinációi és alkalmazásuk vaszkuláris indikációk kezelésére
US7071181B2 (en) 2001-01-26 2006-07-04 Schering Corporation Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
DK1355644T3 (da) 2001-01-26 2006-10-23 Schering Corp Anvendelse af substituerede azetidinonforbindelser til behandling af sitosterolæmi
US7053080B2 (en) 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
JP2005504091A (ja) 2001-09-21 2005-02-10 シェーリング　コーポレイション ステロール吸収阻害剤としてアゼチジノンを用いる黄色腫の処置
US7056906B2 (en) 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
WO2004043457A1 (en) 2002-11-06 2004-05-27 Schering Corporation Cholesterol absorptions inhibitors for the treatment of autoimmune disorders
JP2006519869A (ja) 2003-03-07 2006-08-31 シェーリング　コーポレイション 置換アゼチジノン化合物、置換アゼチジノン化合物を調製するためのプロセス、それらの処方物および使用
CA2517571C (en) 2003-03-07 2011-07-05 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
JP4589919B2 (ja) 2003-03-07 2010-12-01 シェーリング コーポレイション 高コレステロール血症の処置のための、置換アゼチジノン化合物、これらの処方物および使用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5157025A (en) * 1991-04-01 1992-10-20 E. R. Squibb & Sons, Inc. Method for lowering serum cholesterol employing a phosphorus containing ace inhibitor alone or in combination with a cholesterol lowering drug
AU1095695A (en) * 1993-11-09 1995-05-29 Brigham And Women's Hospital Hmg-coa reductase inhibitors in the normalization of vascular endothelial dysfunction
US5957916A (en) * 1994-05-25 1999-09-28 The Trustees Of Columbia University In The City Of New York Myocardial revascularization through the endocardial surface using a laser
US5545628A (en) * 1995-01-10 1996-08-13 Galephar P.R. Inc. Pharmaceutical composition containing fenofibrate
US5648387A (en) * 1995-03-24 1997-07-15 Warner-Lambert Company Carboxyalkylethers, formulations, and treatment of vascular diseases
AU720853B2 (en) * 1995-11-02 2000-06-15 Warner-Lambert Company Method and pharmaceutical composition for regulating lipid concentration
SE506272C2 (sv) * 1996-03-18 1997-11-24 Paul Edholm Förfarande och anordning för att bestämma bildläge och bildvinkel i en röntgenbild
IL117702A0 (en) * 1996-03-28 1996-07-23 Tel Aviv Medical Center Resear Drug for hyperlipoproteinemia
WO1998001100A2 (en) * 1996-07-09 1998-01-15 Merck & Co., Inc. Method for treating homozygous familial hypercholesterolemia
US5861399A (en) * 1996-07-17 1999-01-19 Heart Care Partners Methods and compositions for the rapid and enduring relief of inadequate myocardial function
US6180660B1 (en) * 1997-08-26 2001-01-30 Merck & Co., Inc. Cholesterol-lowering therapy
NZ503982A (en) * 1997-12-12 2002-03-28 Warner Lambert Co Statin-carboxyalkylether combinations useful for treating vascular disorders and diabetes mellitus

Also Published As

Publication number Publication date
AP1708A (en) 2007-01-10
UA73292C2 (en) 2005-07-15
DK1117392T3 (da) 2004-06-14
AU768474B2 (en) 2003-12-11
ZA200102230B (en) 2002-06-18
US20080119561A1 (en) 2008-05-22
JP2002525321A (ja) 2002-08-13
EP1117392B1 (en) 2004-02-25
SI1117392T1 (en) 2004-06-30
ID30255A (id) 2001-11-15
ES2214872T3 (es) 2004-09-16
BG105471A (bg) 2001-12-31
EP1117392A1 (en) 2001-07-25
EA200100370A1 (ru) 2001-10-22
EE200100199A (et) 2002-06-17
CN1342072A (zh) 2002-03-27
HUP0103648A2 (hu) 2003-08-28
CZ20011035A3 (cs) 2001-10-17
AP2001002112A0 (en) 2001-06-30
IS5889A (is) 2001-03-14
SK4122001A3 (en) 2002-06-04
BR9914098A (pt) 2001-07-31
NO20011615D0 (no) 2001-03-29
CA2343299A1 (en) 2000-04-06
YU23901A (sh) 2003-07-07
IL141953A0 (en) 2002-03-10
TR200100901T2 (tr) 2001-08-21
IL141953A (en) 2006-07-05
KR20010079955A (ko) 2001-08-22
EA007427B1 (ru) 2006-10-27
CN1197565C (zh) 2005-04-20
NZ510500A (en) 2003-10-31
HK1042436A1 (en) 2002-08-16
HRP20010236A2 (en) 2002-04-30
ATE260100T1 (de) 2004-03-15
OA11787A (en) 2005-07-26
HUP0103648A3 (en) 2003-10-28
AU4975099A (en) 2000-04-17
DE69915084D1 (de) 2004-04-01
WO2000018395A1 (en) 2000-04-06
PL346980A1 (en) 2002-03-11
DE69915084T2 (de) 2004-07-22
CA2343299C (en) 2008-04-01
PT1117392E (pt) 2004-07-30

Similar Documents

Publication Publication Date Title
DE69831091D1 (de) System zur transmyokardialen revaskularisation
FI981614L (fi) Laakerin kunnon evakuointi
DE69619643D1 (de) Flügelprofil
DK1117669T3 (da) Antiviruspurinderivater
DE69738226D1 (de) Radiofrequenz-Ablationsgerät
NO20011615D0 (no) Fremgangsmåte for forhindring eller forsinkning av kateter- basert revaskularisering
DE59909306D1 (de) Trockenpartie
FI963303A0 (fi) Anordning foer lindning av en invedilingsfilm omlering av vara som skall foerpackas
FI981479A7 (fi) Kuivatusosa
DE69905837D1 (de) Eine verdunstungsschale
DE69925447D1 (de) Kühlbare Schaufelblätter
ATE240308T1 (de) Sulfonamid-derivate
DE69930869D1 (de) Kosmetische schicht
DE59911376D1 (de) Resektionsinstrument
FR2777750B1 (fr) Assaisonnement
DE69924653D1 (de) Trockenpartie
DE59708321D1 (de) Innengekühlte Turbomaschinenschaufel
TR199700071A2 (tr) Tetrahidroizokinolin türevleri.
NO980306D0 (no) Fremgangsmåte for applisering av skje
NO982909D0 (no) LÕseanordning for luke eller lignende
DK1091875T3 (da) Pillesikkert eller pillemodstandsdygtigt lukke
NO20005478D0 (no) FremgangsmÕte for etsing av en Õpning
FI980930A7 (fi) Alus
FI980542A0 (fi) Anordning foer minskning av spaenning eller utmattnings- och brottpaokaenning eller roerelse hos en roerskarv
FI980279A0 (fi) Bladkonstruktion foer en innebandyklubba eller motsvarande

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application